10:21 AM
 | 
Apr 13, 2018
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Abpro planning $69M NASDAQ listing

Antibody company Abpro Corp. (Woburn, Mass.) filed on April 12 to raise up to $69 million in an IPO on NASDAQ underwritten by UBS, Wells Fargo, Nomura and Oppenheimer.

Abpro's two lead programs, ABP-100 and ABP-201,...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >